Memo #4 Portfolio Up 29.9% YTD
Long PODD / Short DXCM: MedTech Spread
The Investment
Public Equity
PODD - Insulet; DXCM - Dexcom
Medical Devices
Time horizon: 1-6 months
Conviction: High
Sizing: Paired L/S position (Gross 30%, Net 0%)
Total Portfolio - Return to Date: 29.9%
Benchmark Returns:
S&P 500 - 8.28% (21.6% Outperformance)
Dow Jones - 8.08% (21.8% Outperformance)
NASDAQ - 7.46% (22.4% Outperformance)
To read further, subscribe to Setlist Capital below.
Subscribe to Default to read the rest.
Become a paying subscriber of Default to get access to this post and other subscriber-only content.
Upgrade